Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

64544-07-6

Cefuroxime axetil

64544-07-6
75975-70-1

Cephradine Monohydrate

75975-70-1
18472-51-0

Chlorhexidine Digluconate 20%in H2O

18472-51-0
85-18-7

Chlorotheophylline-8

85-18-7
77-36-1

Chlorthalidone

77-36-1
96623-56-2

Cinitapride Tartrate

96623-56-2
327-97-9

Chlorogenic acid Hydrate

327-97-9
298-57-7

Cinnarizine

298-57-7
60-27-5

Creatinine anhydrous

60-27-5
97867-33-9

Ciprofloxacin Lactate

97867-33-9
61177-45-5

Clavulanate potassium, microcrystalline cellulose(AVICEL) 1:1 as stabilizer

61177-45-5
3485-62-9

Clidinium Bromide

3485-62-9
24729-96-2

Clindamycin phosphate

24729-96-2
25122-46-7

Clobetasol propionate

25122-46-7
50-41-9

Clomiphene citrate

50-41-9
61177-44-4

Clavulanate Lithium

61177-44-4
303-25-3

Cyclizine HCl

303-25-3
6202-23-9

Cyclobenzaprine HCl

6202-23-9
37158-47-7

Clenpenterol HCl

37158-47-7
55028-72-3

Cloprostenol Sodium

55028-72-3